Proton magnetic resonance spectroscopic imaging in pediatric major depression

被引:78
|
作者
Farchione, TR
Moore, GJ
Rosenberg, DR
机构
[1] Wayne State Univ, Sch Med, Univ Hlth Ctr, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA
关键词
depression; pediatric; child; proton magnetic resonance spectroscopy; dorsolateral prefrontal cortex; brain;
D O I
10.1016/S0006-3223(02)01340-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Neurobiologic abnormalities in dorsolateral prefrontal cortex (DLPFC) are believed to be involved in the pathophysiology of major depressive disorder (MDD). Although MDD commonly emerges during childhood and adolescence, to out-knowledge, no prior study has examined the DLPFC in pediatric patients with MDD. Methods: In this study, choline compounds (Cho), N-acetylaspartate (NAA), and creatine/phosphocreatine (Cr) were measured in left and right DLPFC using a multislice proton magnetic resonance spectroscopic imaging sequence with validated phantom replacement methodology in 11 treatment-naive MDD patients, 10-16 years of age, and 11 case-matched healthy control subjects. Results: A significant increase in Cho was observed in left but not right DLPFC in MDD patients versus control subjects (32.5% higher). No significant differences in NAA or Cr were observed between case-control pairs. Conclusions: These results provide new evidence of localized functional neurochemical marker alterationsi in left DLPFC in pediatric MDD. Our results must be considered preliminary, however, given the small sample size.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 50 条
  • [1] Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma
    Bayram Cirak
    Alena Horská
    Peter B. Barker
    Peter C. Burger
    Benjamin S. Carson
    Anthony M. Avellino
    Child's Nervous System, 2005, 21 : 404 - 409
  • [2] Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma
    Cirak, B
    Horska, A
    Barker, PB
    Burger, PC
    Carson, BS
    Avellino, AM
    CHILDS NERVOUS SYSTEM, 2005, 21 (05) : 404 - 409
  • [3] Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas
    Porto, Luciana
    Kieslich, Matthias
    Franz, Kea
    Lehrbecher, Thomas
    Pilatus, Ulrich
    Hattingen, Elke
    BRAIN TUMOR PATHOLOGY, 2010, 27 (02) : 65 - 70
  • [4] Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas
    Lazareff, JA
    Olmstead, C
    Bockhorst, KHJ
    Alger, JR
    CHILDS NERVOUS SYSTEM, 1996, 12 (03) : 130 - 135
  • [5] Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas
    Luciana Porto
    Matthias Kieslich
    Kea Franz
    Thomas Lehrbecher
    Ulrich Pilatus
    Elke Hattingen
    Brain Tumor Pathology, 2010, 27 : 65 - 70
  • [6] Proton magnetic resonance spectroscopic imaging as a cancer biomarker for pediatric brain tumors (Review)
    Tzika, A. Aria
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (03) : 517 - 526
  • [8] Pediatric low-grade gliomas: Prognosis with proton magnetic resonance spectroscopic imaging
    Lazareff, JA
    Bockhorst, KHJ
    Curran, J
    Olmstead, C
    Alger, JR
    NEUROSURGERY, 1998, 43 (04) : 809 - 817
  • [9] Automated quantitation of proton magnetic resonance spectroscopic imaging
    Rao, SB
    He, RJ
    Mehta, M
    Narayana, PA
    PROCEEDINGS OF THE 25TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: A NEW BEGINNING FOR HUMAN HEALTH, 2003, 25 : 513 - 516
  • [10] Proton magnetic resonance spectroscopic imaging in neurodegenerative diseases
    DVA Medical Center, Department of Radiology, University of California, San Francisco, CA 94121, United States
    Curr. Sci., 6 (800-807):